SCHOTT Pharma AG & Co. KGaA Stock
Equities
1SXP
DE000A3ENQ51
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.92 EUR | -2.46% | -1.10% | -19.88% |
06-05 | SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion | CI |
05-28 | SCHOTT PHARMA : Berenberg reiterates its Neutral rating | ZD |
Sales 2024 * | 976M 1.05B 1.43B | Sales 2025 * | 1.1B 1.18B 1.61B | Capitalization | 4.05B 4.34B 5.93B |
---|---|---|---|---|---|
Net income 2024 * | 144M 154M 211M | Net income 2025 * | 167M 179M 244M | EV / Sales 2024 * | 4.36 x |
Net Debt 2024 * | 200M 215M 293M | Net Debt 2025 * | 188M 202M 275M | EV / Sales 2025 * | 3.86 x |
P/E ratio 2024 * |
27.9
x | P/E ratio 2025 * |
24.5
x | Employees | 4,687 |
Yield 2024 * |
0.58% | Yield 2025 * |
0.68% | Free-Float | 23% |
1 day | -2.46% | ||
1 week | -1.10% | ||
Current month | -8.12% | ||
1 month | -12.08% | ||
3 months | -32.02% | ||
6 months | -20.36% | ||
Current year | -19.88% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Reisse
CEO | Chief Executive Officer | 63 | 22-06-30 |
Director of Finance/CFO | 43 | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eva Kienle
BRD | Director/Board Member | 57 | 23-04-03 |
Wolfgang Wienand
BRD | Director/Board Member | 52 | 23-04-03 |
Chairman | 59 | 23-04-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-25 | 26.92 | -2.46% | 40,693 |
24-06-24 | 27.6 | +4.94% | 75,886 |
24-06-21 | 26.3 | +0.15% | 80,663 |
24-06-20 | 26.26 | +0.31% | 32,906 |
24-06-19 | 26.18 | -3.82% | 58,112 |
Delayed Quote Xetra, June 25, 2024 at 11:35 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.88% | 4.46B | |
-4.16% | 183B | |
-2.39% | 104B | |
-4.08% | 68.18B | |
+16.04% | 47.14B | |
-11.10% | 43.97B | |
+5.84% | 40.95B | |
+17.63% | 31.05B | |
-8.10% | 24.11B | |
+10.88% | 24.05B |
- Stock Market
- Equities
- 1SXP Stock